Skip to main content
logo
Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
4.870
+0.140 (2.96%)
Jul 31, 2026, 3:04 PM CST

SHE:300006 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-135.94-134.71-87.8-8.93-68.71-100.53
Depreciation & Amortization
51.9251.9255.872.7776.4174.76
Other Amortization
1.951.951.262.651.781.42
Loss (Gain) From Sale of Assets
-0.03-0.03-0.49-0.45-0.250.03
Asset Writedown & Restructuring Costs
62.3562.3525.750.710.090.51
Loss (Gain) From Sale of Investments
21.1421.1418.88-85.74-5.78-47.92
Provision & Write-off of Bad Debts
4.284.282.06-1.69-5.59-1.42
Other Operating Activities
17.247.256.98-14.5944.5466.98
Change in Accounts Receivable
49.2749.27239.8751.39142.18-54.29
Change in Inventory
39.5839.580.9927.64-46.6663.34
Change in Accounts Payable
-53.33-53.33-75.35-50.76-20.24118.1
Change in Other Net Operating Assets
---0.382.59-51.46-
Operating Cash Flow
34.7926.04185.0381.5357.13108.28
Operating Cash Flow Growth
-45.47%-85.93%126.94%42.70%-47.24%-51.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-37.1-41.75-78.62-59.32-68.18-38.66
Sale of Property, Plant & Equipment
0.390.310.040.1600.74
Cash Acquisitions
---11.01---
Divestitures
0.780.78--12.29-78.12
Investment in Securities
10.86-19.364.22-60.2980.2114.3
Other Investing Activities
11.858.557.074.641.812.69
Investing Cash Flow
-13.23-51.4-18.31-127.1113.82157.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-294.95391.6294.9352.5171
Short-Term Debt Repaid
------180.91
Long-Term Debt Repaid
--430.79-181.23-362.86-206.88-1,084
Total Debt Repaid
-364.64-430.79-181.23-362.86-206.88-1,265
Net Debt Issued (Repaid)
31.57-135.84210.37-67.96145.62-1,094
Issuance of Common Stock
-----1,065
Common Dividends Paid
-11.41-12.35-10.76-11.8-17.47-29.08
Other Financing Activities
33.0430.22-9.67-1.4837.9194.2
Financing Cash Flow
53.2-117.96189.94-81.24166.0736.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-1.57-0.960.440.572.77-0.86
Net Cash Flow
73.19-144.29357.1-126.25239.79300.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-2.31-15.71106.4122.21-11.0569.63
Free Cash Flow Growth
--379.04%---61.32%
Free Cash Flow Margin
-0.30%-2.02%13.37%2.48%-1.25%5.68%
Free Cash Flow Per Share
-0.00-0.010.100.02-0.010.07
Levered Free Cash Flow
35.6519.0168.2617.68211.44-66.92
Unlevered Free Cash Flow
44.4827.6275.2125.48224.16-46.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
77.5777.39126.87132.63114.96166.12
Change in Working Capital
11.8811.88162.6116.7914.64114.46